Currently out of the existing stock ratings of Kambiz Yazdi, 41 are a BUY (97.62%), 1 are a HOLD (2.38%).

Kambiz Yazdi

Work Performance Price Targets & Ratings Chart

Analyst Kambiz Yazdi, currently employed at BTIG, has had 34.26% of price targets met with an average potential upside of 51.57%, reached in 173 days on average.

Kambiz Yazdi has documented 84 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PRAX, Praxis Precision Medicines at 09-Nov-2026.

Wall Street Analyst Kambiz Yazdi

Analyst best performing recommendations are on ABSI (ABSCI CORP).
The best stock recommendation documented was for ABSI (ABSCI CORP) on 5/28/2026. The price target of $9 was fulfilled within 27 days with a profit of $2.92 (48.03%), with a performance score of 17.79.

Average potential price target upside

PRAX Praxis Precision Medicines ARQT Arcutis Biotherapeutics AVTX Avalo Therapeutics LQDA VTVT ABSI Absci Corp KZIA EYPT Eyepoint Pharmaceuticals HOWL

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 05-May-2025

$189

$-139.13 (-42.40%)

$162

6 days ago
(10-Nov-2026)

Buy Since 18-Jun-2026

$478

$149.87 (45.67%)

$462

6 days ago
(10-Nov-2026)

Hold Since 02-Feb-2026

$343

$14.87 (4.53%)

$362

6 days ago
(10-Nov-2026)

Buy Since 13-Feb-2024

$826

$497.87 (151.73%)

$826

7 days ago
(09-Nov-2026)

5/15 (33.33%)

$548.38 (197.53%)

421

Buy Since 16-Dec-2021

$1201

$872.87 (266.01%)

$1201

1 months 1 days ago
(15-Oct-2026)

18/26 (69.23%)

$952.76 (383.81%)

309

Show more analysts

Please expand the browser size to see the chart

Which stock is Kambiz Yazdi most bullish on?

Potential upside of $497.87 has been obtained for PRAX (PRAXIS PRECISION MEDICINES)

Which stock is Kambiz Yazdi most reserved on?

Potential downside of $4.75 has been obtained for EYPT (EYEPOINT PHARMACEUTICALS)

What Year was the first public recommendation made by Kambiz Yazdi?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?